Pulmonary embolism (PE) remains an important preventable condition with high mortality
and morbidity, recurrence, and sometimes difficult diagnosis. Current treatments have …

Pulmonary embolism (PE) is the leading cause of in-hospital death and the third most
frequent cause of cardiovascular death. The clinical presentation of PE is variable, and …

Abstract Purpose of the Review Over 100,000 cardiovascular-related deaths annually are
caused by acute pulmonary embolism (PE). While anticoagulation has historically been the …

Pulmonary embolism (PE) is a serious and costly disease for patients and healthcare
systems. Guidelines emphasise the importance of differentiating between patients who are …

Opinion statement Submassive pulmonary embolism (PE) represents a patient population
that is under-recognized and under-treated. Recent clinical trials demonstrated the …

Pulmonary embolism (PE) can present with a range of severity. Prognostic risk stratification
is important for efficacious and safe management. This second of two review articles …

Pulmonary embolism (PE) is a common cardiovascular condition that represents a spectrum
of disorders with a gradient of increased risk of adverse outcomes. The US Surgeon General …

Pulmonary embolism (PE) is a potentially life-threatening condition requiring prompt
diagnosis and treatment. Recent advances have led to the development of newer …

Pulmonary embolus (PE) is defined as obstruction of the pulmonary artery or one of its
branches by material (eg, thrombus, tumor, air, or fat) but most commonly due to thrombus …

Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. The
management of PE is currently evolving given the development of new technologies and …